Inbrain Neuroelectronics

Focus: Inbrain Neuroelectronics is a Barcelona-based biotechnology company pioneering neuroelectric therapies using graphene-based brain interfaces for neurological disorders. The company operates as a pre-revenue, early-stage biotech focused on a novel therapeutic modality with limited public scale data.

Neurology

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Open Jobs

Should You Work at Inbrain Neuroelectronics?

AI assessment

Best suited for early-stage career builders or deep-tech specialists willing to accept pre-clinical risk in exchange for outsized equity upside and frontier innovation exposure.

Why Work Here

Opportunity to build a company from ground level in a cutting-edge frontier (graphene neuroelectronics) with significant IP potential and differentiated technology vs. incumbent neural stimulation players.

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

INBRAIN Graphene Cortical Interface

Brain Tumor

N/A

Clinical Trials (1)

NCT06368310FIH Clinical Investigation of Graphene Electrodes for Brain Mapping

N/A

Help build intelligence for Inbrain Neuroelectronics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Watch Out For

Zero clinical trials and no disclosed funding or revenue create material uncertainty about runway, capitalization strategy, and near-term value inflection events.
Early-stage graphene-based implant technology carries unvalidated manufacturing, biocompatibility, and regulatory risks that could delay or derail development timelines.
Limited headcount (12 active roles) and lack of public financials suggest modest scale, potentially constrained career mobility and departmental depth compared to established biotech.

Inbrain Neuroelectronics

Should You Work at Inbrain Neuroelectronics?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (12)

Data Architect

Senior Test Systems Engineer

Electronics Technician

Electronics Team Manager

IT Team Lead

Project Manager (with Medical devices experience)

Cleanroom Technician

Sr. Electronics Engineer

Embedded Software Architect

Mechanical Team Manager

System Engineer

Senior Mechanical Engineer (with Medical Devices Experience)

Hiring Trend